 |
 |
Hi again Sinead & All, Here's a bit more info... Guilford Pharmaceuticals Presents Research Results http://www.alssurvivalguide.com/als_news/991028guilford_pharmaceuticals_present.htm Neuroimmunophilin Ligands http://heskco.com/karan/pages/newbna.htm Pharmalicensing.com News - May 3 2000 http://www.pharmalicensing.com/news/headlines/941066651_3817899b0ed78 Drug Development and Clinical Trials - Amgen and Guilford Pharmaceuticals Inc. Small molecule neurotrophic agents http://www.alsa.org/research/drugdev2.cfm Potential Parkinson's Disease Cure Drug repairs brain's nerve cells, banishes most disease symptoms in animal trials http://www.parkinson.org/cure.htm National Parkinson Foundation Questions and Answers for the Announced Potential Parkinson's Disease Cure http://www.parkinson.org/cureqna.htm > On 3 May 2000, at 10:06, Sinead Aungier wrote: > > > Does anyone know where on the web I can find out what the current status is > > on the research for GPI-1-46? > > > > Sinead > > Hi Sinead, > > BACKGROUND.... > GUILFORD ACHIEVES DEVELOPMENT MILESTONE > IN NEUROIMMUNOPHILIN PARTNERSHIP WITH AMGEN > Monday 28 September 1998 > http://www.prnewswire.co.uk/prn-cgi/release?26478 > > Guilford Pharmaceuticals Products > http://www.guilfordpharm.com/fs_products_nf.htm > > For updated information, please contact > Amgen Professional Services at 1-800-772-6436 or by fax 805-376-8550. > > Dial up or Send them a fax and give us the results... > > All the best ....... murray > > [log in to unmask] Cheers ... murray [log in to unmask]